CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-8.77%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.1B
AUM Growth
+$1.1B
(-21%)
Cap. Flow
-$3.57M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
46.92%
Holding
73
New
12
Increased
10
Reduced
33
Closed
7
Top Buys
| 1 |
argenx
ARGX
|
$25M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$19.4M |
| 3 |
Twist Bioscience
TWST
|
$16.3M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$14.4M |
| 5 |
Sarepta Therapeutics
SRPT
|
$9.82M |
Top Sells
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$40.7M |
| 2 |
Nektar Therapeutics
NKTR
|
$27.1M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$26M |
| 4 |
Omeros
OMER
|
$24.4M |
| 5 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$8.4M |
Sector Composition
| 1 | Healthcare | 96.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $74.3M | 6.03% | 1,751,699 -58,301 | -3% | -$2.47M |
|
2
AnaptysBio
ANAB
$569M
| $70.5M | 5.73% | 1,105,557 -29,443 | -3% | -$1.88M |
|
|
TSRO
3
DELISTED
TESARO, Inc.
TSRO
| $66.8M | 5.43% | 900,000 -350,000 | -28% | -$26M |
|
4
Apellis Pharmaceuticals
APLS
$3.48B
| $59.4M | 4.82% | 4,502,498 +330,000 | +8% | +$4.35M |
|
5
InflaRx
IFRX
$108M
| $53.7M | 4.36% | 1,475,140 +133,600 | +10% | +$4.86M |
|
|
6
argenx
ARGX
$43.6B
| $43.2M | 3.51% | 450,000 +260,000 | +137% | +$25M |
|
|
PRNB
7
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $40.4M | 3.28% | 1,474,362 -12,536 | -0.8% | -$343K |
|
|
RETA
8
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $37.8M | 3.07% | 674,251 +14,251 | +2% | +$799K |
|
|
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $37.2M | 3.02% | 3,481,471 -75,198 | -2% | -$804K |
|
10
Kezar Life Sciences
KZR
$28.9M
| $33.6M | 2.73% | 1,422,911 -130,000 | -8% | -$3.07M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $33.1M | 2.69% | 677,451 -22,549 | -3% | -$1.1M |
|
|
QTNT
12
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $29.1M | 2.37% | 4,762,772 -87,228 | -2% | -$534K |
|
13
Rocket Pharmaceuticals
RCKT
$354M
| $28.8M | 2.34% | 1,945,659 +445,000 | +30% | +$6.59M |
|
|
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $24M | 1.95% | 650,000 +390,000 | +150% | +$14.4M |
|
15
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $23.3M | 1.9% | 831,000 | – | – |
|
16
Theravance Biopharma
TBPH
$699M
| $22.6M | 1.84% | 884,916 -215,084 | -20% | -$5.5M |
|
|
TECX
17
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $22.6M | 1.84% | 1,357,784 -135,000 | -9% | -$2.25M |
|
18
Ascendis Pharma
ASND
$11.8B
| $21.2M | 1.72% | 338,456 -11,544 | -3% | -$723K |
|
|
BPMC
19
DELISTED
Blueprint Medicines
BPMC
| $19.5M | 1.58% | 361,351 -18,649 | -5% | -$1.01M |
|
|
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
| $19.4M | 1.58% | +1,285,828 | New | +$19.4M |
|
|
GTHX
21
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $19M | 1.55% | 994,287 +353,806 | +55% | +$6.78M |
|
|
ZGNX
22
DELISTED
Zogenix, Inc.
ZGNX
| $18.6M | 1.51% | 511,395 +11,395 | +2% | +$415K |
|
23
Zai Lab
ZLAB
$3.68B
| $18.3M | 1.48% | 787,426 -20,740 | -3% | -$482K |
|
|
24
Nektar Therapeutics
NKTR
$568M
| $18M | 1.46% | 547,000 -823,000 | -60% | -$27.1M |
|
|
SAGE
25
DELISTED
Sage Therapeutics
SAGE
| $17.6M | 1.43% | 183,732 -6,268 | -3% | -$600K |
|